Snow David P. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jun 26, 2018
Insider Transaction Report
Form 4
Snow David P.
Chief Business Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-06-25+200,000→ 200,000 totalExercise: $18.85Exp: 2028-06-25→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]One third (1/3) of the shares underlying the option shall vest on June 25, 2019 (the "Cliff Vesting Date"), the remainder of the grant shall vest in equal installments on each quarterly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.